Canopy Growth Corporation
CGC Healthcare Drug Manufacturers Specialty & Generic
Canopy Growth Corporation’s revenue for fiscal 2026 (year ended March 2026) was $206.0 million, up 6.55% from fiscal 2025. In the quarter to June 2026, revenue grew 12.4%, EPS grew 87.5%, free cash flow fell 117.6% and total debt fell 18.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years, operating cash flow growth for three.
Follow CGC
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
+8 more quarters Free account |
220.46 | 269.96 | 267.61 | 246.80 |
Receivables |
19.50 | 23.34 | 26.27 | 30.76 | |
Inventory |
74.31 | 75.71 | 79.99 | 77.62 | |
Total current assets |
323.62 | 376.34 | 383.23 | 365.74 | |
Property, Plant, Equpment (Net) |
209.65 | 204.46 | 229.08 | 224.78 | |
Long-Term Investments |
137.25 | 111.29 | 78.18 | 90.63 | |
Goodwill and Intangible Assets (Total) |
93.92 | 88.73 | 107.19 | 104.13 | |
Long-term assets (Other) |
12.16 | 12.66 | 12.06 | 12.08 | |
Total non-current assets |
452.98 | 417.13 | 426.51 | 431.62 | |
Total Assets |
776.60 | 793.47 | 809.74 | 797.36 | |
Accounts Payable |
13.16 | 14.32 | 25.20 | 20.66 | |
Accrued Expenses |
28.62 | 31.39 | 31.12 | 34.03 | |
Current Part of Debt |
1.34 | — | 11.75 | 20.82 | |
Other current liabilities |
15.75 | 24.80 | 46.61 | 44.93 | |
Total current liabilities |
58.87 | 70.51 | 114.68 | 120.45 | |
Long Term Debt (Total) |
164.30 | 161.38 | 157.15 | 152.68 | |
Long Term Tax Liability (Deferred) |
— | — | 5.93 | 5.72 | |
Non-current Liabilities (Other) |
19.16 | 17.74 | 27.05 | 21.12 | |
Total non-current liabilities |
183.45 | 179.13 | 190.14 | 179.51 | |
Total liabilities |
242.32 | 249.63 | 304.82 | 299.96 | |
Additional Paid In Capital |
1,898.21 | 1,876.16 | 1,875.88 | 1,871.20 | |
Common Stock (Net) |
6,589.97 | 6,577.60 | 6,683.26 | 6,670.78 | |
Retained Earnings |
(7,964.07) | (7,914.64) | (8,061.85) | (8,055.67) | |
Common Equity (Total) |
534.27 | 543.84 | 504.92 | 497.40 | |
Shareholders Equity (Total) |
534.27 | 543.84 | 504.92 | 497.40 | |
Shareholders Equity and Liabilities (Total) |
776.60 | 793.47 | 809.74 | 797.36 | |
Shares (Common) |
332.38 | 368.29 | 422.07 | 423.02 | |
Shareholders Equity (Tangible) |
440.35 | 455.11 | 397.73 | 393.27 | |
Net Debt |
(54.83) | (108.58) | (98.70) | (73.30) | |
Total Debt |
165.64 | 161.38 | 168.91 | 173.50 |